CAD 2.1
(-7.89%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -2.82 CAD | -1466.67% |
2022 | -0.18 CAD | 91.3% |
2021 | -2.07 CAD | 34.29% |
2020 | -3.15 CAD | -1066.67% |
2019 | -0.27 CAD | -139.71% |
2018 | 0.68 CAD | 251.11% |
2017 | -0.45 CAD | -903.57% |
2016 | 0.06 CAD | 157.44% |
2015 | -0.10 CAD | 18.75% |
2014 | -0.12 CAD | 33.33% |
2013 | -0.18 CAD | -124.44% |
2012 | -0.08 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.30 CAD | -57.89% |
2024 Q3 | 0.03 CAD | 109.0% |
2024 Q1 | -0.19 CAD | 53.66% |
2023 Q2 | -0.10 CAD | -240.5% |
2023 Q3 | -2.65 CAD | -2677.78% |
2023 Q4 | -0.41 CAD | 84.53% |
2023 Q1 | 0.07 CAD | 442.93% |
2023 FY | - CAD | -1466.67% |
2022 Q4 | -0.02 CAD | -120.0% |
2022 Q3 | -0.01 CAD | 30.77% |
2022 Q2 | -0.01 CAD | 18.75% |
2022 FY | - CAD | 91.3% |
2022 Q1 | -0.02 CAD | 81.52% |
2021 Q2 | -1.14 CAD | -67.65% |
2021 Q3 | -0.06 CAD | 95.09% |
2021 Q4 | -0.09 CAD | -54.64% |
2021 Q1 | -0.68 CAD | 15.0% |
2021 FY | - CAD | 34.29% |
2020 Q3 | -2.05 CAD | -1105.88% |
2020 Q4 | -0.80 CAD | 60.98% |
2020 FY | - CAD | -1066.67% |
2020 Q1 | -0.02 CAD | 84.21% |
2020 Q2 | -0.17 CAD | -669.23% |
2019 Q4 | -0.14 CAD | 48.15% |
2019 Q1 | 0.92 CAD | 557.14% |
2019 Q3 | -0.27 CAD | -35.0% |
2019 FY | - CAD | -139.71% |
2019 Q2 | -0.20 CAD | -121.74% |
2018 Q3 | 0.09 CAD | 155.56% |
2018 FY | - CAD | 251.11% |
2018 Q4 | 0.14 CAD | 52.17% |
2018 Q2 | 0.04 CAD | 165.81% |
2018 Q1 | -0.05 CAD | -181.96% |
2017 Q1 | -0.03 CAD | -583.33% |
2017 Q2 | -0.24 CAD | -589.66% |
2017 Q3 | -0.09 CAD | 61.46% |
2017 Q4 | -0.02 CAD | 79.03% |
2017 FY | - CAD | -903.57% |
2016 Q3 | 0.03 CAD | 600.0% |
2016 Q4 | 0.01 CAD | -74.29% |
2016 FY | - CAD | 157.44% |
2016 Q1 | -0.02 CAD | -7650.0% |
2016 Q2 | 0.00 CAD | 126.49% |
2015 Q2 | -0.05 CAD | 24.77% |
2015 Q1 | -0.06 CAD | 28.75% |
2015 Q4 | 0.00 CAD | -97.5% |
2015 FY | - CAD | 18.75% |
2015 Q3 | 0.01 CAD | 116.56% |
2014 Q4 | -0.09 CAD | -3006.9% |
2014 Q2 | -0.01 CAD | 91.56% |
2014 Q1 | -0.09 CAD | -1377.05% |
2014 FY | - CAD | 33.33% |
2014 Q3 | -0.00 CAD | 61.84% |
2013 Q2 | -0.03 CAD | 76.42% |
2013 Q1 | -0.12 CAD | -309.56% |
2013 Q3 | -0.00 CAD | 98.59% |
2013 Q4 | -0.01 CAD | -1425.0% |
2013 FY | - CAD | -124.44% |
2012 FY | - CAD | 0.0% |
2012 Q3 | -0.01 CAD | 87.59% |
2012 Q2 | -0.04 CAD | -874.42% |
2012 Q1 | -0.00 CAD | 30.65% |
2012 Q4 | -0.03 CAD | -463.46% |
2011 Q2 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q4 | -0.01 CAD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Aurora Cannabis Inc. | -1.60 CAD | -76.25% |
Avicanna Inc. | -0.09 CAD | -2929.001% |
Avant Brands Inc. | -0.61 CAD | -362.295% |
Cardiol Therapeutics Inc. | -0.44 CAD | -540.909% |
Crescita Therapeutics Inc. | -0.10 CAD | -2777.551% |
Knight Therapeutics Inc. | -0.16 CAD | -1662.5% |
MediPharm Labs Corp. | -0.04 CAD | -7733.333% |
Canopy Growth Corporation | -8.79 CAD | 67.918% |
Willow Biosciences Inc. | -0.10 CAD | -2720.0% |
Auxly Cannabis Group Inc. | -0.04 CAD | -6180.624% |